Literature DB >> 24858592

Urinary cystatin C as an early biomarker of acute kidney injury after open and endovascular abdominal aortic aneurysm repair.

Konstantinos M Pirgakis1, Konstantinos Makris2, Ilias Dalainas3, Andreas M Lazaris4, Chrisostomos K Maltezos5, Christos D Liapis3.   

Abstract

BACKGROUND: Acute kidney injury (AKI) after open repair (OR) and endovascular repair (EVAR) of abdominal aortic aneurysm (AAA) is associated with increased mortality and hospital costs. Early detection of AKI is critical to prevent its progression. Recent findings demonstrate that elevated levels of urinary cystatin C (uCysC) may reflect tubular dysfunction. We prospectively evaluated whether uCysC can detect renal dysfunction earlier than serum creatinine (sCr).
METHODS: In a prospective study, 126 consecutive patients (mean age ± SD, 69.1 ± 8.66 years) with AAA (EVAR = 87, OR = 39) were enrolled. sCr and uCysC were measured preoperatively (baseline) and at 6, 24, and 48 hr postoperatively. A final measurement was made on day 5. AKI was defined according to Acute Kidney Injury Network criteria.
RESULTS: The incidence of AKI was significantly higher (χ(2) test, P < 0.05) in the OR group (n = 13, 33%) than in the EVAR group (n = 15, 17%). The baseline median (interquartile range) value of uCysC was significantly higher (t-test, P < 0.05) in patients of both groups (OR-EVAR) who developed AKI from those who did not (OR/AKI group: 0.06 [0.02-0.12] mg/L, EVAR/AKI group: 0.08 [0.05-0.11] mg/L versus no-AKI subjects: 0.04 [0.02-0.07] mg/L). Subsequent analysis showed that at 6 hr postoperatively, the patients who developed AKI increased their uCysC levels significantly from baseline (OR/AKI group: 0.58 [0.42-0.70] mg/L, EVAR/AKI group: 0.59 [0.30-1.07] mg/L). The median value of uCysC in AKI patients increased at 24 hr (OR/AKI group: 1.37 [0.78-3.40] mg/L, EVAR/AKI group: 2.11 [0.70-2.42] mg/L) and peaked at 48 hr (OR/AKI group: 6.16 [1.74-10.73] mg/L, EVAR/AKI group: 2.57 [1.21-7.40] mg/L), while no increase was observed among those who did not develop AKI at the same time points (0.06 [0.04-0.14] vs. 0.08 [0.04-0.19] mg/L). The diagnostic accuracy of uCysC at 6 hr post-surgery was excellent (area under the curve - receiver-operating characteristic [AUC-ROC] = 0.968), significantly higher than sCr (AUC-ROC = 0.844) and a cutoff value set at 0.30 mg/L can diagnose AKI with a sensitivity of 85.71% and a specificity of 98.97%.
CONCLUSIONS: uCysC is superior to sCr in the early diagnosis of AKI following open and endovascular AAA repair.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858592     DOI: 10.1016/j.avsg.2014.04.006

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  14 in total

1.  Acute kidney injury after abdominal aortic aneurysm repair: current epidemiology and potential prevention.

Authors:  Liesa Zabrocki; Frank Marquardt; Klaus Albrecht; Stefan Herget-Rosenthal
Journal:  Int Urol Nephrol       Date:  2017-12-11       Impact factor: 2.370

Review 2.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

Review 3.  Novel biomarkers for prognosticating diabetic kidney disease progression.

Authors:  Shilna Muttickal Swaminathan; Indu Ramachandra Rao; Srinivas Vinayak Shenoy; Attur Ravindra Prabhu; Pooja Basthi Mohan; Dharshan Rangaswamy; Mohan V Bhojaraja; Shivashankara Kaniyoor Nagri; Shankar Prasad Nagaraju
Journal:  Int Urol Nephrol       Date:  2022-10-22       Impact factor: 2.266

4.  Impact of retrograde intrarenal surgery on biomarkers that are associated with renal parenchyma injury, a preliminary study.

Authors:  Lara Stächele; Daniel J Stekhoven; Jan A Birzele; Martin Risch; Räto T Strebel
Journal:  World J Urol       Date:  2022-01-23       Impact factor: 4.226

5.  Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.

Authors:  Xian-Fei Zeng; Dong-Xue Lu; Jun-Min Li; Yun Tan; Zhuo Li; Lei Zhou; Zeng-Qian Xi; Shu-Miao Zhang; Wei Duan
Journal:  BMC Nephrol       Date:  2017-07-12       Impact factor: 2.388

6.  The level of urinary IL-18 in acute kidney injury after cardiopulmonary bypass.

Authors:  Changan Wang; Jinghua Zhang; Jianle Han; Qingyan Yang; Jinrui Liu; Bing Liang
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

7.  Early term effect of ureterorenoscopy (URS) on the Kidney: research measuring NGAL, KIM-1, FABP and CYS C levels in urine.

Authors:  Erdal Benli; Sema Nur Ayyildiz; Selma Cirrik; Tevfik Noyan; Ali Ayyildiz; Abdullah Cirakoglu
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

8.  Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran.

Authors:  Mitra Javanmardi; Namam-Ali Azadi; Sabrieh Amini; Mohammad Abdi
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

9.  The incidence, risk factors and in-hospital mortality of acute kidney injury in patients after abdominal aortic aneurysm repair surgery.

Authors:  Ying Tang; Junzhe Chen; Kai Huang; Dan Luo; Peifen Liang; Min Feng; Wenxin Chai; Erik Fung; Hui Yao Lan; Anping Xu
Journal:  BMC Nephrol       Date:  2017-05-31       Impact factor: 2.388

10.  Neutrophil gelatinase-associated lipocalin and acute kidney injury in endovascular aneurysm repair or open aortic repair: a pilot study.

Authors:  Benedetta Rampoldi; Serena Tessarolo; Paola Giubbilini; Paola Gaia; Samantha D Corino; Sarah Mazza; Roberta Rigolini; Marco Dei Poli; Elena Vianello; Massimiliano M Corsi Romanelli; Elena Costa
Journal:  Biochem Med (Zagreb)       Date:  2018-01-10       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.